Programme

Keynote lecture: "Scalable generation of custom-made immune cells for innovative cell-based immunotherapies and industrial applications"

Nico Lachmann, MHH Medizinische Hochschule Hannover

"Process design considerations for hMSC-based products"

Jan Barekzai; Florian Petry; Peter Czermak; Denise Salzig,
Technische Hochschule Mittelhessen

Poster talk: "Biomimetic matrices enable highly defined isolation of functional mesenchymal stromal cells in xeno-/serum-free media"

Kristina Thamm¹; Kristin Moebus²; Russel Towers²; Richard Wetzel¹;
Manja Wobus²; Sandra Segeletz², ¹ denovoMATRIX GmbH; ² University Hospital
Carl Gustav Carus der Technischen Universität Dresden

Short break

Session: Therapeutic exosomes
Chair: Denise Salzig, University of Applied Sciences Mittelhessen, Gießen

Keynote lecture: "Functional extracellular vesicles as new therapeutic modality – Exosomes’ Road to the clinic"

Jens Gruber, Curexsys GmbH, Göttingen

Poster talk: "Challenges and Solutions for Production of Therapeutic Exosomes"
Christoph Keysberg, Kerstin Otte, Biberach University of Applied Sciences

Lunch

Session: New approaches in cell-based therapies
Chair: Hansjörg Hauser, Helmholtz Centre for Infection Research, Braunschweig

Keynote lecture: "Engineering T cell receptors for adoptive cell therapy"

Kilian Schober, Universitätsklinikum Erlangen

"Cell-mediated visualization of local infections and drug delivery "

Dagmar Wirth¹; Mario Köster¹; Sandhya Kumar¹; Peter Behrens²; Hansjörg Hauser¹; Andreas Kirschning³, ¹ Helmholtz Zentrum für Infektionsforschung mbH; ² Institute for Anorganic Chemistry; Leibniz University Hannover; ³ Institute for Organic Chemistry, Leibnitz University Hannover

Keynote lecture: "Harnessing human 3D Cell Models to accelerate the development of advanced therapies"

Catarina Brito, iBET & ITQB-NOVA, Oeiras/Portugal

Keynote lecture: "Application of mRNA technology in cancer therapy"

Felicitas Müller, BioNTech SE, Mainz

"Improved production strategies for oncolytic Measles virus as therapeutic
cancer treatment"

Dustin Eckhardt; Denise Salzig; Peter Czermak, Technische Hochschule Mittelhessen

Keynote lecture: "Home brewn CAR-T-Cell"

Michael Schmitt, Uniklinik Heidelberg, Heidelberg

"Running title: Modular mini-factories for the automated and scalable production of ATMPs"

Andreas Traube; Jessica Horbelt; Martin Thoma; Natalie Gebken; Sarah Kleine-Wechelmann; Milena Frahm; Markus Schandar; Michael Klinger; Sebastian Puls; Rolf Wössner; Michael Pfeifer; Tobias Sauer, Fraunhofer IPA

"Real laboratory for automated and digitalized ATMP production"

Georg Popp¹; Rolf van Lengen²; Andreas Traube³; Karsten Seidl⁴; Carsten Claussen⁵; Michael Baßler⁶; Paul Franz¹; Anna Dünkel¹; Ulrike Köhl¹; Stephan Fricke¹,
¹ Fraunhofer IZI; ² Fraunhofer IESE; ³ Fraunhofer IPA; ⁴ Fraunhofer IMS; ⁵ Fraunhofer ITMP; ⁶ Fraunhofer IMM

Keynote lecture: "Tackling the Challenges of AAV Vector Manufacturing"

Nicole Faust, CEVEC Pharmaceuticals GmbH, Köln

"Risk Assessment – An intelligent tool for the evaluation of critical starting material"

Claudia Papewalis¹; Marco Schmeer²; Martin Schleef², ¹ Valicare GmbH;
² PlasmidFactory GmbH

"Plausibility of EP Patents - Post-filed experimental data as support of
sufficiency of disclosure and inventive step of the Invention?!"

Anna Katharina Heide, RUHR-IP Patentanwälte, Essen

"The current regulatory framework of ATMP storage and distribution – consequences and challenges "

Andrea Zobel, World Courier

End of conference